CLINICAL_TRIALS
trial_result
· 2022-05-26
Clinical Trial Update: Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis [Phase 3]
Summary
Phase 3 safety and efficacy study of Ravulizumab in adults with Generalized Myasthenia Gravis completed and results posted. The trial assessed Ravulizumab’s imp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: COMPLETED | Results posted: 2022-05-26